SPNE - SPNE STOCK NEWS

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the commercial launch of its NorthStar OCT Posterior Cervical Fixation System, marking its first new product launch since 2007. This system targets a market exceeding $250 million in the U.S. NorthStar OCT features innovative instrumentation designed for clinical and economic efficiency, addressing complex cervical deformities. The product integrates with existing systems for enhanced surgical performance. The company aims to improve surgical flow and outcomes through this advanced system, broadening its offerings in spinal care solutions.

SeaSpine Holdings Corporation (NASDAQ: SPNE) has successfully completed the first clinical cases in the U.S. and Australia using its 7D Percutaneous Spine Module. This innovation enhances the 7D Flash™ Navigation System, targeting the $4 billion minimally invasive spine surgery market. Surgeons report improved navigation accuracy and reduced radiation exposure. The system leverages advanced imaging technology to streamline procedures. SeaSpine aims to provide significant economic value and improve surgical workflows for hospitals and surgical centers worldwide.

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its 7D FLASH Navigation System has received an Innovative Technology contract from Vizient, Inc., enhancing its recognition in the healthcare sector. This contract, awarded outside the standard bidding process, signifies the system's unique capabilities that may improve clinical care and patient safety. The 7D FLASH Navigation System utilizes proprietary camera-based technology that minimizes radiation exposure, positioning SeaSpine as a leader in navigation solutions. This contract expands SeaSpine's accessibility to a vast network of healthcare providers.

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the receipt of CE Mark certification for its Cranial Module and Percutaneous Spine Module, enhancing the 7D FLASH™ Navigation System. This advancement broadens its applications in cranial and spine surgery within the European market. The FLASH Navigation System is renowned for its speed and accuracy, using visible light and machine-vision algorithms. SeaSpine aims to leverage this milestone to penetrate further into Europe, emphasizing the clinical value delivered by its innovative technologies.

SeaSpine Holdings Corporation, a medical technology company focused on spinal disorder solutions, announced its participation in the Cantor Virtual Global Healthcare Conference on September 27, 2021, at 8:00 am ET. The event will feature a live and archived webcast accessible via the Company's Investor Relations page.

SeaSpine specializes in surgical solutions, offering a diverse range of orthobiologics and spinal implants aimed at improving surgical outcomes. The company operates in the U.S. and approximately 30 other countries, supported by a dedicated distribution network.

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced an Analyst & Investor Event in Boston on September 30, 2021, from 7:30 a.m. to 8:45 a.m. ET. The event will feature remarks from the leadership team discussing the company’s innovative technologies and growth strategies. A live webcast, including a slide presentation, will be available on their website, with an archived replay following the event. SeaSpine specializes in surgical solutions for spinal disorders, offering a wide range of orthobiologics and spinal implants to support various surgical procedures.

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the limited commercial launch of the Mariner Adult Deformity Pedicle Screw System, designed for complex spine surgeries. This system enhances surgical efficiency with advanced instrumentation and the 7D Flash Navigation technology, aiming to reduce the need for intraoperative radiation. Dr. Pawel Jankowski highlighted its potential to improve workflows in challenging surgical cases. The launch brings new tools that promise reduced operating room clutter and lower processing costs for hospitals, expanding SeaSpine’s product portfolio in spinal disorder solutions.

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the limited commercial launch of its 3D-printed WaveForm A (ALIF) Interbody System, designed for anterior lumbar interbody fusion procedures. The innovative system integrates with the Meridian anterior interbody portfolio and features a porous design to enhance graft accommodation. The modular design allows for personalized fusion constructs, balancing crucial factors such as subsidence resistance and imaging visibility. This marks SeaSpine's fifth entry into the 3D-printed interbody market, reflecting ongoing innovation in spinal surgical solutions.

On August 1, 2021, SeaSpine Holdings Corporation (NASDAQ: SPNE) granted inducement awards to nine non-executive employees under the 2020 Employment Inducement Equity Incentive Award Plan. The awards included options for 43,750 shares and restricted stock units for 3,200 shares, with an exercise price of $19.59 per share, matching the closing price on July 30, 2021. The options will vest 50% after two years and the remaining 50% in quarterly installments. The restricted stock units will vest in three equal installments over three years. These awards were approved by the independent compensation committee.